Cabio Biotech (Wuhan) Co., Ltd.
Status: Publicly traded
Direct answer
Cabio Biotech (Wuhan) Co., Ltd. is publicly traded on SHH under the ticker 688089.SS.
Cabio Biotech (Wuhan) Co., Ltd. focuses on the development, production, and worldwide distribution of crucial nutritional compounds such as arachidonic acid (ARA), docosahexaenoic acid (DHA), and beta-carotene. These ingredients are primarily supplied to manufacturers, both within China and internationally, who specialize in infant formula and healthy food products. The company's versatile offerings are incorporated...
Can you invest in Cabio Biotech (Wuhan) Co., Ltd.?
Yes. Cabio Biotech (Wuhan) Co., Ltd. trades publicly on SHH as 688089.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Cabio Biotech (Wuhan) Co., Ltd.
Detailed equity research is provided by MarketSnap.